Latest Artemisinin Stories
Anti-malarial drugs are being used inappropriately for sick children in Zambia with fevers and difficulty breathing â€“ a problem that can be addressed by arming community health workers with a simple rapid-diagnostic test and a supply of antibiotics.
Novartis announced today that scientists at the Novartis Institute for Tropical Diseases (NITD), in collaboration with researchers from the Genomics Institute of the Novartis Research Foundation (GNF), the Swiss Tropical and Public Health Institute and The Scripps Research Institute have discovered a novel compound that shows promise as a next generation treatment for drug resistant malaria.
As part of the Â£1.5 million project, researchers are now testing the drug to determine how the treatment could progress to clinical trials.
Current tools for combating malaria, such as artemisinin-combination therapy and increasing coverage of long-lasting insecticide bednets can result in major reductions in Plasmodium falciparum malaria transmission and the associated disease burden in Africa.
In 2007, an estimated 656 million fevers occurred in African children aged 0-4 years, with 78 million children of the 183 million attending a public health care facility likely to have been infected with P. falciparum (range 60-103 million), the parasite that causes the most dangerous form of malaria.
Scientists said on Thursday that synthetic biology can be used to make instant vaccines, inexpensive medicines and even nonpolluting fuel, but it will take time.
As part of a multicenter study, UT Southwestern Medical Center researchers have identified a series of chemical compounds that might serve as starting points for the identification of new classes of anti-malarial drugs.
WASHINGTON, April 20 /PRNewswire-USNewswire/ -- Congressional Malaria Champions today received over 20,000 signatures from people around the world supporting efforts to eliminate malaria.
Global funding to help fight malaria in Africa has increased 10-fold since 2004, but more funding is needed to help reduce deaths caused by the disease.
The first results from a large-scale study of key antimalarial medicines in ten Sub-Saharan African countries reveal that a high percentage of medicines circulating on national markets are of substandard quality and thus may contribute to the growth of drug-resistant strains of Plasmodium falciparum, the most virulent form of malaria.
- To swell, as grain or wood with water.